AUROBINDO PHARMA LTD FDA Approval ANDA 209017

ANDA 209017

AUROBINDO PHARMA LTD

FDA Drug Application

Application #209017

Application Sponsors

ANDA 209017AUROBINDO PHARMA LTD

Marketing Status

Over-the-counter001

Application Products

001FOR SOLUTION;ORAL17GM/SCOOPFUL0POLYETHYLENE GLYCOL 3350POLYETHYLENE GLYCOL 3350

FDA Submissions

UNKNOWN; ORIG1AP2018-04-09STANDARD
LABELING; LabelingSUPPL2AP2022-12-07STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209017
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"POLYETHYLENE GLYCOL 3350","activeIngredients":"POLYETHYLENE GLYCOL 3350","strength":"17GM\/SCOOPFUL","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/09\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-04-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.